U.S. Universities Lead in Biotechnology Research, Tech Transfer, and Commercialization of IP
Despite growing efforts by universities around the world to catch up, the U.S. remains the global powerhouse in biotechnology research and in the ability to turn research into commercial applications, according to a new study from the Milken Institute.
This examination of the commercialization of university research reveals that the U.S. dominates the top rankings on many key measures, including published research, patents issued, and licensing income.
The study, “Mind to Market: A Global Analysis of University Biotechnology Transfer and Commercialization,” shows the position of these institutions in the commercialization pipeline, which starts with the quality of research and moves to patented ideas and, finally, to commercial outcomes.
The report found that U.S. universities hold eight of the top 10 positions on a measure of the quality and quantity of published biotech research. Also, Of the top 10 universities, nine are American when scored on the quality and quantity of biotechnology patents issued in the U.S.
According to the Milken Institute University Technology Transfer and Commercialization Index, the following universities are the leaders at taking worldclass research and turning it into commercial applications: